Irinotecan Hydrochloride Liposome
First-line Treatment of Metastatic Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd.Phase 3
—
Rating in progress
Irinotecan Hydrochloride Liposome in First-line Treatment of Metastatic Pancreatic Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active